DE2118842A1 - Mixing vessel for inhalation therapy with powdery substances - Google Patents
Mixing vessel for inhalation therapy with powdery substancesInfo
- Publication number
- DE2118842A1 DE2118842A1 DE19712118842 DE2118842A DE2118842A1 DE 2118842 A1 DE2118842 A1 DE 2118842A1 DE 19712118842 DE19712118842 DE 19712118842 DE 2118842 A DE2118842 A DE 2118842A DE 2118842 A1 DE2118842 A1 DE 2118842A1
- Authority
- DE
- Germany
- Prior art keywords
- mixing vessel
- inhalation therapy
- powdery substances
- inhalation
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002156 mixing Methods 0.000 title claims description 17
- 238000002664 inhalation therapy Methods 0.000 title claims description 3
- 239000000126 substance Substances 0.000 title description 2
- 239000003814 drug Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Mischgefäß fUr die Inhalationstherapie mit pulverförmigen Stoffen Die Erfindung betrifft ein einfaches,handliches Mischgefäß zum Mischen von pulverförmigen Medikamenten mit Atemluft in solcher Weise, daß insbesondere ein homogener Niederschlag auf den Schleimhäuten der oberen Luftwege erreicht wird. Das Mischgefäß soll im Hinblick auf eine intensive Anwendung klein, leicht und einfach zu handhaben sein, damit es Personen stets bei sich tragen können. Durch die häufige Anwendung geringer Dosen sollen in den oberen Luftwegen hohe Konzentrationen über lange Zeit aufrecht erhalten werden,die auf anderem Wege nicht zugänglich sind. Mixing vessel for inhalation therapy with powdery substances The invention relates to a simple, handy mixing vessel for mixing powdery Medicines with breathing air in such a way that in particular a homogeneous precipitation is reached on the mucous membranes of the upper respiratory tract. The mixing vessel should be in Be small, light and easy to use for intensive use, so that people can always carry it with them. Less due to frequent use Doses are designed to maintain high concentrations in the upper airways over a long period of time that are not accessible in any other way.
Bekannt sind auf dem Prinzip der Zerstäubung arbeitende Inhalationsgeräte, die meist stationdr verwendet werden, weil sie an eine Energiequelle gebunden sind.Inhalation devices working on the principle of atomization are known, which are mostly used stationdr because they are tied to an energy source.
Der Erfindung liegt die Aufgabe zugrunde, die Inhalationsapparatur so zu vereinfachen, daß sie von Erwachsenen und Kindern jederzeit angewendet werden kann.The invention is based on the object of the inhalation apparatus simplified so that they can be used by adults and children at all times can.
Diese Aufgabe wird erfindungsgemäß dadurch gelöst, daß die Packung eines pulverförmigen Medikaments zugleich als Mischgefäß dient. Dazu wird z.B.This object is achieved according to the invention in that the pack a powdered drug also serves as a mixing vessel. For this purpose e.g.
eine Weithalsflasche mit einem Verschluß ausgerUstet, durch den zwei verschließbare Röhrchen geführt sind. Das Verhältnis ihrer lichten Querschnitte soll möglichst 1:5 betragen, damit während des Einatmens durch das dickere Röhrchen der gebündelte Luftstrahl, der durch das dUnnere in die Flasche einströmt, das Pulver aufwirbelt. Die gewünschte homogene Beladung der Luft mit Pulver wird erreicht, wenn das Gefäß nur zu einem Drittel oder weniger gefüllt ist. Das dickere Röhrchen trägt ein ver#tellbares Mundstück, das die Aufgabe hat in bekannter Weise Beiluft in gewUnschter Menge einstellen zu können. Durch die Beiluft wird das Medikament weit, ja bis in die Bronchien,getragen.a wide-neck bottle equipped with a cap through which two sealable tubes are guided. The ratio of their clear cross-sections should be 1: 5 if possible, so that during inhalation through the thicker tube the bundled jet of air flowing into the bottle through the thinner one, the powder stirs up. The desired homogeneous loading of the air with powder is achieved, if the jar is only a third or less full. The thicker tube carries an adjustable mouthpiece that has the task of providing air in the known way to be able to adjust in the desired amount. The medication is in the air far, yes to the bronchi, carried.
Die mit der Erfindung erzielbaren Vorteile bestehen insbesondere darin, daß anstelle eines Inhalationsapparates eine Medikamentpackung zugleich als Mischgefaß dient. Das Mischgefäß ist wegen der fertigungstechnisch einfachen Form als "Wegwerfpockung" geeignet. Am Beispiel der in einer größeren Versuchsreihe erprobten Anwendung des Mischgefäßes zur Inhalation von Vitamin C (Ascorbinsdure) werden die erzielbaren Vorteile besonders deutlich. Nach Auftreten der ersten Symptome kann man Grippe und akute entzUndliche Affektionen der oberen Luftwege durch Inhalation von Vitamin C-Pulver aus diesem Mischgefa#ß im Taschenformat bei stUndllcher Wiederholung verhUten oder stark mildern, obwohl dabei nur ca. 100 mg tdglich verbraucht werden. Eine Dosis die erfahrungsgemß gut vertragen wird. Auch Kleinkinder gewöhnen sich sehr schnell an diese Form der Vitamingab@e Vergleichbare Heilerfolge werden bei peroaler Vitamin C-Gabe bisher nur mit Überdosen erreicht (s.o.The advantages that can be achieved with the invention are, in particular, that instead of an inhaler, a drug pack also acts as a mixing vessel serves. The mixing vessel is called "disposable pocking" because of its simple form in terms of production technology. suitable. Using the example of the application of the Mixing vessel for the inhalation of vitamin C (ascorbic acid) are achievable Advantages particularly clear. After the first symptoms appear, you can get the flu and acute inflammatory diseases of the upper respiratory tract from inhalation of vitamins Avoid repeating C-powder from this pocket-sized mixing vessel over and over again or reduce it significantly, although only about 100 mg are consumed per day. One Dose that experience has shown is well tolerated. Even toddlers get used to it a lot quickly to this form of vitamin consumption. Comparable healing successes are achieved with peroaler Vitamin C has only been administered with overdoses so far (see above.
Scheunert, Miegl u.a., Lit.-Dienst Roche, Jan. 1959).Scheunert, Miegl et al., Lit.-Dienst Roche, Jan. 1959).
Im lebenden Organismus wird vitasin C durch Tabakgebrauch zersetzt und man fUhrt verschiedene Raucherschüden auf C-Mangel zurUck (Endokrinolo gie 1953, S. 345)e Dieser Mangel kann aus den handlichen Mischgefäß lokal und zeitlich optimal beseitigt werden.In the living organism, vitasin C is broken down by tobacco use and various smoking injuries are attributed to carbon deficiency (Endocrinology 1953, P. 345) e This deficiency can be optimally achieved locally and in terms of time from the handy mixing vessel be eliminated.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712118842 DE2118842A1 (en) | 1971-04-19 | 1971-04-19 | Mixing vessel for inhalation therapy with powdery substances |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712118842 DE2118842A1 (en) | 1971-04-19 | 1971-04-19 | Mixing vessel for inhalation therapy with powdery substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2118842A1 true DE2118842A1 (en) | 1972-11-09 |
Family
ID=5805087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712118842 Pending DE2118842A1 (en) | 1971-04-19 | 1971-04-19 | Mixing vessel for inhalation therapy with powdery substances |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2118842A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0377174A3 (en) * | 1988-12-22 | 1990-11-22 | Büsselmann, Manfred | Method and apparatus for spraying and atomising liquids |
| EP0404454A1 (en) * | 1989-06-21 | 1990-12-27 | FISONS plc | Disposable medicament inhalation device |
| US5239991A (en) * | 1989-06-21 | 1993-08-31 | Fisons Plc | Disposable powder medicament inhalation device with peel-off cover |
-
1971
- 1971-04-19 DE DE19712118842 patent/DE2118842A1/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0377174A3 (en) * | 1988-12-22 | 1990-11-22 | Büsselmann, Manfred | Method and apparatus for spraying and atomising liquids |
| EP0404454A1 (en) * | 1989-06-21 | 1990-12-27 | FISONS plc | Disposable medicament inhalation device |
| US5239991A (en) * | 1989-06-21 | 1993-08-31 | Fisons Plc | Disposable powder medicament inhalation device with peel-off cover |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69230613T2 (en) | METHOD AND DEVICE FOR DISPENSING MEDICINES IN AEROSOL FORM | |
| DE845385C (en) | Device for administering medicaments by inhalation | |
| DE69605760T2 (en) | FAN DEVICE | |
| DE69133584T4 (en) | Apparatus for treating a pulmonary constriction and asthma | |
| DE69534755T2 (en) | Device for the administration of phosphodiesterase inhibitors | |
| EP0611577B1 (en) | Powder inhalator | |
| DE69426415T2 (en) | INTRAPULMONARY HORMONE DELIVERY SYSTEM | |
| Várai et al. | A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease | |
| DE69724202T2 (en) | Method and device for mixing gases | |
| CH680651A5 (en) | ||
| YU49083B (en) | Process for obtaining pharmaceutical composition containing budesonide and formoterol | |
| EE03221B1 (en) | Pharmaceutical formulations for inhalation, the process for their preparation and the inhaler for their use | |
| Scott et al. | Plasma lignocaine concentrations following endotracheal spraying with an aerosol | |
| Robertson et al. | Evaluation of doxapram for arousal from general anaesthesia in outpatients | |
| DE69823561T2 (en) | inhalers | |
| DE3940389A1 (en) | Therapeutical compsn. comprising gas, e.g. oxygen dissolved in liq. - for immuno-stimulation in cancer therapy, reviving accident victims and improving oxygen transport in vascular coronary diseases | |
| DE60000325T2 (en) | Therapeutic use of a helium / oxygen mixture, especially for the treatment of asthma | |
| DE3602370A1 (en) | Use of analgesics by inhalation | |
| DE2118842A1 (en) | Mixing vessel for inhalation therapy with powdery substances | |
| DE69506085T2 (en) | AEROSOL PRODUCTION METHOD | |
| DE3852717T2 (en) | Composition for the prophylaxis of Pneumocystis carinii pneumonia. | |
| DE69917658T3 (en) | MICRONIZED PHARMACEUTICAL COMPOSITIONS | |
| Karetzky | Acute asthma: The use of subcutaneous epinephrine in therapy | |
| DE60202299T2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING SALMETEROL AND BUDESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES | |
| Mørch et al. | Fluothane compared to chloroform and ether in mice |